Pentapharm AG

Pentapharm AG is a Swiss manufacturer of active pharmaceutical ingredients (APIs), diagnostic reagents, and biochemical products founded in 1948 and headquartered in Aesch, Basel-Landschaft. Specializing in hemostasis, coagulation, and anticoagulation therapies, the company supplies the pharmaceutical and diagnostic industries with naturally derived APIs including Aprotinin, Batroxobin, and Haemocoagulase—all supported by Drug Master Files (DMFs) and CEP certificates. The company manufactures standardized biochemicals for research, quality control, and analytical applications; highly purified snake venom enzymes for plasma coagulation and fibrinolysis modulation; proteinase inhibitors for proteolytic control; and synthetic peptide substrates (chromogenic, fluorogenic, amperogenic) for diagnostic assay development and proteinase activity monitoring. Pentapharm also develops and produces in-vitro diagnostic (IVD) reagent kits and research-use-only (RUO) kits for coagulation and fibrinolysis analysis. All manufacturing operates under GMP standards with strong emphasis on regulatory compliance, quality assurance, and accelerated time-to-market for partner pharmaceutical and diagnostics companies.